Condition
Acute Lymphocytic Leukemia Refractory clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Acute Lymphocytic Leukemia Refractory clinical trials that are recruiting, at sites in 3 countries (most in Australia (1), United States (1), Germany (1)). By phase: Phase 1/2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
CTD402 for relapsed or refractory T-ALL and T-LBL
This trial will test whether a single infusion of CTD402 UCART can be safe and shrink cancer in people age 12 and older with relapsed or refractory T‑cell acute lymphoblastic leukemia or lymphoblastic lymphoma.
-
Using Tafasitamab to treat children with relapsed or refractory acute B-lineage leukemia
This study is testing a new treatment called Tafasitamab to see if it can help children with hard-to-treat acute leukemia stay healthy longer after their stem cell transplant.
Related topics
Quick answers
How many Acute Lymphocytic Leukemia Refractory clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Australia (1 trial), United States (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.